Transcription of EASL–EORTC Clinical Practice Guidelines: …
{{id}} {{{paragraph}}}
EASL EORTC Clinical Practice Guidelines: Managementof hepatocellular carcinomaEuropean Association for the Study of the Liver ,European Organisation for Research and Treatment of CancerIntroductionEASL EORTC Clinical Practice Guidelines (CPG) on the manage-ment of hepatocellular carcinoma (HCC) define the use of surveil-lance, diagnosis, and therapeutic strategies recommended forpatients with this type of cancer. This is the first European jointeffort by the European Association for the Study of the Liver(EASL) and the European Organization for Research and Treat-ment of Cancer (EORTC) to provide common guidelines for themanagement of hepatocellular carcinoma . These guidelinesupdate the recommendations reported by the EASL panel ofexperts in HCC published in 2001 [1]. Several Clinical and scien-tific advances have occurred during the past decade and, thus, amodern version of the document is urgently purpose of this document is to assist physicians, patients,health-care providers, and health-policy makers from Europe andworldwide in the decision-making process according to evidence-based data.
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver⇑, European Organisation for Research and Treatment of Cancer
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}